NCT00008203View on ClinicalTrials.gov

Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 1996

Primary Completion Date

December 31, 2005

Study Completion Date

May 31, 2008

Conditions
Breast Cancer
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

recombinant interferon gamma

DRUG

carboplatin

DRUG

cyclophosphamide

DRUG

cyclosporine

DRUG

thiotepa

PROCEDURE

autologous bone marrow transplantation

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

10032

Herbert Irving Comprehensive Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Herbert Irving Comprehensive Cancer Center

OTHER

NCT00008203 - Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer | Biotech Hunter | Biotech Hunter